Reporter Nov 21 2014
Nov. 20, 2014—A group of Vanderbilt-led investigators has identified a new gene mutation that may explain why some breast cancer patients do not respond to anti-hormone therapy.
Nov. 20, 2014—With research and development costs for many drugs reaching well into the billions, pharmaceutical companies want more than ever to determine whether their drugs already at market have any hidden therapeutic benefits that could warrant putting additional indications on the label and increasing production.
Nov. 20, 2014—A new protocol put into place more than a year ago at Monroe Carrell Jr. Children’s Hospital at Vanderbilt is showing early signs of improving outcomes for patients with traumatic brain injuries.
Nov. 20, 2014—The most emergent form of heart attacks is decreasing nationwide, but this declining incidence could affect emergency departments’ quality and timeliness of care.
Nov. 20, 2014—Elise McMillan, J.D., received the Mollie Burd Gavigan Service Award from the Down Syndrome Association of Middle Tennessee (DSAMT) in recognition of McMillan’s “instrumental role in improving the lives of individuals with Down syndrome in Middle Tennessee.” The award was presented recently at the annual DSAMT Buddy Race.
Nov. 20, 2014—When Kendra Kaufman walked into to a recent follow-up appointment with surgeon Dai Chung, M.D., the only help she needed to steady her steps came from ankle-foot-orthotics.